LEHIGH VALLEY, PA – September 4, 2018 – (Uni-flo2), a breakthrough patient-centric solution that ensures continuous oxygen flow equivalent to the low flow dual-pronged cannula but with half the skin contact, points to its benefits for patients with congestive heart failure (CHF) who require supplemental oxygen therapy. CHF patients welcome an inconspicuous, lightweight single cannula that not only may optimize oxygen absorption and improve health, but also introduces a life-changing enhancement for improved appearance.
“Treatment compliance is critical to ensure that the CHF patient is getting enough , and the introduction of the Uni-flo2 single cannula supports this objective,” says Campbell Cauthen, Registered Respiratory Therapist and co-inventor, Uni-flo2. “Patients living with CHF may also experience chronic obstructive pulmonary disease and have difficulty breathing. With continuous reliance upon supplemental oxygen therapy, these patients appreciate greater comfort and freedom of movement when utilizing the Uni-flo2. Of course, enhanced personal appearance is always appreciated by men and women alike.”
Nasal cannulas and face masks are typically used in treatment of people who have respiratory related conditions such as asthma, pneumonia, and cardiac issues.
“Uni-flo2 is designed to conform to facial contours which eliminates facial and neck irritation,” adds Cauthen. “Our growing community of patients also report improved sleep and ability to eat and smell. It’s always gratifying to hear from patients who tell us that they especially like the way they look with a single cannula.”
Developed, manufactured and distributed by UPODS LLC., the Uni-flo2 Single Nasal Cannula is lightweight, eliminates half the skin contact and opportunity for infection, and improves patient freedom of movement, comfort, eating, sleeping and personal appearance. Uni-flo2 conforms to all facial contours with a strain relief system that ensures continuous low flow oxygen equivalent to the dual-pronged cannula. Designed with patient dignity, comfort and safety in mind for home care specialists, clinicians, assisted living facilities, hospitals and other healthcare providers. Uni-flo2 holds Patent No. 9,440,039 and Patent No. 9,925,348. Visit